Exact Mass: 1268.6400800000001

Exact Mass Matches: 1268.6400800000001

Found 29 metabolites which its exact mass value is equals to given mass value 1268.6400800000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Soyasaponin A1

(2S,3S,4S,5R,6R)-6-{[(3S,4S,4aR,6aR,6bS,8aR,9S,10R,12aS,14aR,14bR)-9-{[(2S,3R,4S,5S)-3,5-dihydroxy-4-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-10-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl]oxy}-5-{[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxyoxane-2-carboxylic acid

C59H96O29 (1268.6036966)


Soyasaponin A1 is found in pulses. Soyasaponin A1 is isolated from soybean (Glycine max).

   

Goserelin

Goserelin

C59H84N18O14 (1268.6414083999998)


L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02A - Hormones and related agents > L02AE - Gonadotropin releasing hormone analogues C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1910 - Gonadotropin-releasing Hormone Analog D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D000970 - Antineoplastic Agents

   

Goserelin

(2S)-1-[(2S)-2-{[(2S)-2-{[(2R)-3-(tert-butoxy)-2-{[(2S)-2-{[(2S)-1,3-dihydroxy-2-{[(2S)-1-hydroxy-2-{[(2S)-1-hydroxy-2-({hydroxy[(2S)-5-hydroxy-3,4-dihydro-2H-pyrrol-2-yl]methylidene}amino)-3-(1H-imidazol-5-yl)propylidene]amino}-3-(1H-indol-3-yl)propylidene]amino}propylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxypropylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-5-carbamimidamidopentanoyl]-N-[(C-hydroxycarbonimidoyl)amino]pyrrolidine-2-carboximidate

C59H84N18O14 (1268.6414083999998)


Goserelin is a synthetic hormone. In men, it stops the production of the hormone testosterone, which may stimulate the growth of cancer cells. In women, goserelin decreases the production of the hormone estradiol (which may stimulate the growth of cancer cells) to levels similar to a postmenopausal state. When the medication is stopped, hormone levels return to normal. L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02A - Hormones and related agents > L02AE - Gonadotropin releasing hormone analogues C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1910 - Gonadotropin-releasing Hormone Analog D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D000970 - Antineoplastic Agents

   
   
   

3beta,20S,24S-trihydroxydammar-25-en-21,28-dioic acid 3-O-{[alpha-L-rhamnopyranosyl(1->2)][alpha-L-rhamnopyranosyl(1->6)-beta-D-glucopyranosyl(1->3)]-alpha-L-arabinopyranosyl}-21-O-beta-D-glucopyranoside

3beta,20S,24S-trihydroxydammar-25-en-21,28-dioic acid 3-O-{[alpha-L-rhamnopyranosyl(1->2)][alpha-L-rhamnopyranosyl(1->6)-beta-D-glucopyranosyl(1->3)]-alpha-L-arabinopyranosyl}-21-O-beta-D-glucopyranoside

C59H96O29 (1268.6036966)


   

3-O-beta-D-xylopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->3)-beta-D-glucopyranosyl bayogenin-28-O-beta-D-glucopyranosyl ester|caryocaroside III-14

3-O-beta-D-xylopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->3)-beta-D-glucopyranosyl bayogenin-28-O-beta-D-glucopyranosyl ester|caryocaroside III-14

C59H96O29 (1268.6036966)


   

3beta,20S,25-trihydroxydammar-23-en-21,28-dioic acid 3-O-{[alpha-L-rhamnopyranosyl(1->2)][alpha-L-rhamnopyranosyl(1->6)-beta-D-glucopyranosyl(1->3)]-alpha-L-arabinopyranosyl}-21-O-beta-D-glucopyranoside

3beta,20S,25-trihydroxydammar-23-en-21,28-dioic acid 3-O-{[alpha-L-rhamnopyranosyl(1->2)][alpha-L-rhamnopyranosyl(1->6)-beta-D-glucopyranosyl(1->3)]-alpha-L-arabinopyranosyl}-21-O-beta-D-glucopyranoside

C59H96O29 (1268.6036966)


   

3-O-beta-D-glucopyranosyl (1?6)-beta-D-glucopyranosyl-28-O-beta-D-glucopyranosyl(1?6)[alpha-L-rhamnopyranosyl(1?2)]-beta-D-glucopyranosyl 16-deoxybarringtogenol C|3-O-beta-D-glucopyranosyl(1->6)-beta-D-glucopyranosyl-28-O-beta-D-glucopyranosyl(1->6)[alpha-L-rhamnopyranosyl(1->2)]-beta-D-glucopyranosyl-16-deoxy-barringtogenol C|xanifolia O54

3-O-beta-D-glucopyranosyl (1?6)-beta-D-glucopyranosyl-28-O-beta-D-glucopyranosyl(1?6)[alpha-L-rhamnopyranosyl(1?2)]-beta-D-glucopyranosyl 16-deoxybarringtogenol C|3-O-beta-D-glucopyranosyl(1->6)-beta-D-glucopyranosyl-28-O-beta-D-glucopyranosyl(1->6)[alpha-L-rhamnopyranosyl(1->2)]-beta-D-glucopyranosyl-16-deoxy-barringtogenol C|xanifolia O54

C60H100O28 (1268.6400800000001)


   
   

3beta,20S,29-trihydroxydammar-24-en-21-carboxylic acid 3-O-{[alpha-L-rhamnopyranosyl-(1-2)]-[alpha-L-rhamnopyranosyl-(1-3)]-beta-D-glucopyranosyl}-21-O-[beta-D-glucopyranosyl-(1-2)]-beta-D-glucopyranoside

3beta,20S,29-trihydroxydammar-24-en-21-carboxylic acid 3-O-{[alpha-L-rhamnopyranosyl-(1-2)]-[alpha-L-rhamnopyranosyl-(1-3)]-beta-D-glucopyranosyl}-21-O-[beta-D-glucopyranosyl-(1-2)]-beta-D-glucopyranoside

C60H100O28 (1268.6400800000001)


   

12beta-O-acetyl-20-O-benzoyltomentogenin 3-O-beta-D-glucopyranosyl-(1->4)-6-deoxy-3-O-methyl-beta-D-allopyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-D-oleandropyranosyl-(1->4)-beta-D-cymaropyranoside

12beta-O-acetyl-20-O-benzoyltomentogenin 3-O-beta-D-glucopyranosyl-(1->4)-6-deoxy-3-O-methyl-beta-D-allopyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-D-oleandropyranosyl-(1->4)-beta-D-cymaropyranoside

C64H100O25 (1268.655335)


   

3-O-beta-D-xylopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->3)-beta-D-glucopyranosyl bayogenin|caryocaroside III-15

3-O-beta-D-xylopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->3)-beta-D-glucopyranosyl bayogenin|caryocaroside III-15

C59H96O29 (1268.6036966)


   

3-O-β-D-glucopyranosyl-(1?2)-β-D-glucopyranosyl-28-O-α-L-rhamnopyranosyl-(1?2)-[β-D-glucopyranosyl-(1?6)]-β-D-glucopyranosy-21β,22α-dihydroxyl-olean-12-ene

3-O-β-D-glucopyranosyl-(1?2)-β-D-glucopyranosyl-28-O-α-L-rhamnopyranosyl-(1?2)-[β-D-glucopyranosyl-(1?6)]-β-D-glucopyranosy-21β,22α-dihydroxyl-olean-12-ene

C60H100O28 (1268.6400800000001)


   

3-O-beta-D-glucopyranosyl-2beta,3beta,23-trihydroxyolean-12-en-28-oic acid-28-O-beta-D-xylopyranosyl-(1?6)-[beta-D-glucopyranosyl-(1?2)]-[beta-D-glucopyranosyl-(1?3)]-beta-D-glucopyranoside

3-O-beta-D-glucopyranosyl-2beta,3beta,23-trihydroxyolean-12-en-28-oic acid-28-O-beta-D-xylopyranosyl-(1?6)-[beta-D-glucopyranosyl-(1?2)]-[beta-D-glucopyranosyl-(1?3)]-beta-D-glucopyranoside

C59H96O29 (1268.6036966)


   

12-O-cinnamoylsarcostin 3-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->4)-beta-D-oleandropyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-D-cymaropyranoside

12-O-cinnamoylsarcostin 3-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->4)-beta-D-oleandropyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-D-cymaropyranoside

C63H96O26 (1268.6189516)


   

(S)-jalapinolic acid 11-O-alpha-L-rhamnopyranosyl-(1->3)-O-[2-O-trans-cinnamoyl-3-O-isobutanoyl-alpha-L-rhamnopyranosyl-(1->4)]-O-[2-O-(S)-2-methylbutyryl]-alpha-L-rhamnopyranosyl-(1->4)-O-alpha-L-rhamnopyranosyl-(1->2)-O-beta-D-fucopyranoside 1,3 ester|batatoside A

(S)-jalapinolic acid 11-O-alpha-L-rhamnopyranosyl-(1->3)-O-[2-O-trans-cinnamoyl-3-O-isobutanoyl-alpha-L-rhamnopyranosyl-(1->4)]-O-[2-O-(S)-2-methylbutyryl]-alpha-L-rhamnopyranosyl-(1->4)-O-alpha-L-rhamnopyranosyl-(1->2)-O-beta-D-fucopyranoside 1,3 ester|batatoside A

C64H100O25 (1268.655335)


   

(11S)-[[O-alpha-L-rhamnopyranosyl-(1- >3)-O-[(2-O-trans-cinnamoyl)-(4-O-isobutanoyl)-alpha-L-rhamnopyranosyl-(1- >4)]-O-2-O-(2S)-methylbutanoyl-alpha-L-rhamnopyranosyl-(1- >4)-O-alpha-L-rhamnopyranosyl-(1- >2)-beta-D-fucopyranosyl]oxy]-jalapinoic acid intramolecular 1,2-ester

(11S)-[[O-alpha-L-rhamnopyranosyl-(1- >3)-O-[(2-O-trans-cinnamoyl)-(4-O-isobutanoyl)-alpha-L-rhamnopyranosyl-(1- >4)]-O-2-O-(2S)-methylbutanoyl-alpha-L-rhamnopyranosyl-(1- >4)-O-alpha-L-rhamnopyranosyl-(1- >2)-beta-D-fucopyranosyl]oxy]-jalapinoic acid intramolecular 1,2-ester

C64H100O25 (1268.655335)


   

Saikosaponin U|Saikosaponin V2

Saikosaponin U|Saikosaponin V2

C59H96O29 (1268.6036966)


   

Actinomycin X2|isoactinomycin-X2|[B3-(4-oxo-L-proline)]-actinomycin-D

Actinomycin X2|isoactinomycin-X2|[B3-(4-oxo-L-proline)]-actinomycin-D

C62H84N12O17 (1268.6077094)


   

3beta,20S-dihydroxydammar-24-en-21-carboxylic acid 3-O-{[alpha-L-rhamnopyranosyl-(1-2)]-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl}-21-O-[beta-D-glucopyranosyl-(1-2)]-beta-D-glucopyranoside

3beta,20S-dihydroxydammar-24-en-21-carboxylic acid 3-O-{[alpha-L-rhamnopyranosyl-(1-2)]-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl}-21-O-[beta-D-glucopyranosyl-(1-2)]-beta-D-glucopyranoside

C60H100O28 (1268.6400800000001)


   

PIM3 30:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C57H105O28P (1268.652966)


   

Leuprolide acetate

(Des-Gly10,D-Leu6,Pro-NHEt9)-LHRH acetate salt

C61H88N16O14 (1268.6665588)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1910 - Gonadotropin-releasing Hormone Analog D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D012102 - Reproductive Control Agents > D005299 - Fertility Agents D000970 - Antineoplastic Agents

   
   

2-amino-9-N-[(3R,6S,7R,10S,16S)-10-butan-2-yl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3-propan-2-yl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxo-1-N-[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide

2-amino-9-N-[(3R,6S,7R,10S,16S)-10-butan-2-yl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3-propan-2-yl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxo-1-N-[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide

C63H88N12O16 (1268.6440928)


   

H-DL-Pyr-DL-His-DL-Trp-DL-Ser-DL-Tyr-DL-Ser(tBu)-DL-Leu-Arg-DL-Pro-NHNHCONH2

H-DL-Pyr-DL-His-DL-Trp-DL-Ser-DL-Tyr-DL-Ser(tBu)-DL-Leu-Arg-DL-Pro-NHNHCONH2

C59H84N18O14 (1268.6414083999998)


   

2-amino-4,6-dimethyl-3-oxo-9-N-[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15,18-hexaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-1-N-[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide

2-amino-4,6-dimethyl-3-oxo-9-N-[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15,18-hexaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-1-N-[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide

C62H84N12O17 (1268.6077094)


   
   

Gp100 (25-33), human (TFA)

Gp100 (25-33), human (TFA)

C54H83F3N16O16 (1268.6124754)


Gp100 (25-33), human TFA (Hgp100 (25-33) TFA) is the amino acids 25-33 fragment of the human melanoma antigen. It is a 9-amino acid (AA) epitope restricted by H-2Db and recognized by the T cells[1].